Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias
- 1 July 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 56 (1) , 84-88
- https://doi.org/10.1016/0002-9149(85)90571-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.Circulation, 1983
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- IV. ANTIARRHYTHMIC AGENTSThe Lancet, 1980
- Atypical ventricular tachycardia as a manifestation of disopyramide toxicityThe American Journal of Cardiology, 1978
- Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: Comparison of propranolol, procainamide and quinidineThe American Journal of Cardiology, 1978
- Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.Circulation, 1978
- Management of patients with malignant ventricular arrhythmiasThe American Journal of Cardiology, 1977
- Antiarrhythmic and electrocardiographic effects of single oral doses of disopyramideEuropean Journal of Clinical Pharmacology, 1977
- Intermittent Intravenous Procaine Amide to Treat Ventricular ArrhythmiasAnnals of Internal Medicine, 1973
- The effect of oral quinidine on intraventricular conduction in man: Correlation of plasma quinidine with changes in QRS durationAmerican Heart Journal, 1970